PHK
ADVM

Point72 Hong Kong’s Adverum Biotechnologies ADVM Stock Holding History

Point72 Hong Kong’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-66
Closed -$1K – 1856
2022
Q1 		$1K Buy
+66
New +$966 ﹤0.01% 1746
2021
Q4 		– Sell
-274
Closed -$6K – 1839
2021
Q3 		$6K Buy
+274
New +$6.99K ﹤0.01% 1820
2021
Q2 		– Sell
-213
Closed -$21K – 1877
2021
Q1 		$21K Buy
+213
New +$25.6K ﹤0.01% 1458
2020
Q4 		– Sell
-409
Closed -$42K – 1682
2020
Q3 		$42K Buy
+409
New +$61.3K ﹤0.01% 713
2020
Q2 		– Sell
-26
Closed -$3K – 1112
2020
Q1 		$3K Buy
+26
New +$3.03K ﹤0.01% 820

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Point72 Hong Kong's ADVM Position: Q2 2022 in Review

Point72 Hong Kong sold out of Adverum Biotechnologies (ADVM) in Q2 2022, closing a stake of 66 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in ADVM in Q1 2020 and held it in 5 quarters. The position peaked at $42K in Q3 2020. 77 funds tracked by Wall St. Rank hold ADVM as of Q2 2022.

  • Point72 Hong Kong reported no remaining Adverum Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 66 Adverum Biotechnologies shares in Q2 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in Adverum Biotechnologies in Q1 2020 and held it in 5 quarters.
  • Point72 Hong Kong's Adverum Biotechnologies position peaked at $42K in Q3 2020.
  • 77 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.